What is Theravance Biopharma's net margin?

Theravance Biopharma (TBPH) reported net margin of 104.3% in Q1 2026.

How has Theravance Biopharma's net margin changed year-over-year?

Theravance Biopharma's net margin increased by 216.7% year-over-year, from -89.4% to 104.3%.

What is the long-term trend for Theravance Biopharma's net margin?

Over 5 years (2020 to 2025), Theravance Biopharma's net margin has grown at a -23.9% compound annual growth rate (CAGR), from -386.9% to 98.5%.

What does net margin mean?

Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.

Theravance Biopharma TBPH Net margin

Net margin at other companies

Zevra Therapeutics, Inc.ZVRA

101.6%+60.1pp

LQD

Liquidia CorporationLQDA

-176.2%-76.4pp

Royalty PharmaRPRX

33.9%-14.4pp

United TherapeuticsUTHR

40.6%+0.2pp

Aurinia PharmaceuticalsAUPH

100%+83.9pp

PrecigenPGEN

-3,656%—

Other financials

Income statement

See full

Revenue$17.7M+15.0%

Operating income-$9.5M+34.3%

Net income-$4.9M+63.7%

EPS (diluted)-$0.10+63.0%

Balance sheet

See full

Cash & equivalents$288.1M+160%

Total debt$40.5M-15.9%

Total equity$290.6M+75.1%

Total assets$472.3M+37.5%

Cash flow

See full

Operating cash flow$73.3M+70.3%

CapEx$8.0K-95.8%

Free cash flow$59.6M+5,560%

Valuation

See full

Market cap$890.32M+67.5%

Enterprise value$642.72M+37.0%

P/E7.8×—

P/S8.1×0.0×

Profitability

See full

Gross margin60.8%—

Operating margin1.2%+0.6pp

FCF margin221.9%+206pp

Returns & leverage

See full

Return on equity50.2%+36.2pp

Debt / equity0.1×-0.2×

Current ratio13.1×+8.4×

Where this comes from

Calculated from Theravance Biopharma’s reported figures.

net income/total revenue=104.3%

Based on trailing twelve months.

The official record: Theravance Biopharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Theravance Biopharma's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Theravance Biopharma's net margin?: Theravance Biopharma (TBPH) reported net margin of 104.3% in Q1 2026.
How has Theravance Biopharma's net margin changed year-over-year?: Theravance Biopharma's net margin increased by 216.7% year-over-year, from -89.4% to 104.3%.
What is the long-term trend for Theravance Biopharma's net margin?: Over 5 years (2020 to 2025), Theravance Biopharma's net margin has grown at a -23.9% compound annual growth rate (CAGR), from -386.9% to 98.5%.
What does net margin mean?: Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.